Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 89.2218.691.19-0.11-4.07

What is the latest Core EBITDA Growth ratio of VENUS REMEDIES ?

The latest Core EBITDA Growth ratio of VENUS REMEDIES is 89.22 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202689.22
Mar202518.69
Mar20241.19
Mar2023-0.11
Mar2022-4.07

How is Core EBITDA Growth of VENUS REMEDIES Trending?

Years Core EBITDA Growth % Change
Mar2026 89.22
377.37
Mar2025 18.69
1,470.59
Mar2024 1.19
Positive
Mar2023 -0.11
Negative
Mar2022 -4.07 -

Other Financial Ratios of VENUS REMEDIES


Compare Core EBITDA Growth ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹2,077.0 Cr -4.7% -14.3% 237.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,716.0 Cr 0.1% -0.6% 15.2% Stock Analytics
DIVIS LABORATORIES ₹248,120.0 Cr -0.6% 8.7% 53% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,038.0 Cr -0.8% -1.7% 34.7% Stock Analytics
CIPLA ₹110,858.0 Cr -0.6% -4.2% -12.9% Stock Analytics
DR REDDYS LABORATORIES ₹97,828.7 Cr 2.7% -0.7% -12.1% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-4.7%

-14.3%

237.6%

SENSEX

-0.6%

-4.4%

-8.7%


You may also like the below Video Courses